Drug-Induced Liver Injury in Patients With Preexisting Chronic Liver Disease in Drug Development: How to Identify and Manage?

被引:39
作者
Chalasani, Naga [1 ]
Regev, Arie
机构
[1] Indiana Univ Sch Med, Indianapolis, IN 46202 USA
关键词
HYS LAW; STANDARDIZATION; RISK;
D O I
10.1053/j.gastro.2016.10.010
中图分类号
R57 [消化系及腹部疾病];
学科分类号
100201 [内科学];
摘要
引用
收藏
页码:1046 / 1051
页数:6
相关论文
共 25 条
[1]
Case Definition and Phenotype Standardization in Drug-Induced Liver Injury [J].
Aithal, G. P. ;
Watkins, P. B. ;
Andrade, R. J. ;
Larrey, D. ;
Molokhia, M. ;
Takikawa, H. ;
Hunt, C. M. ;
Wilke, R. A. ;
Avigan, M. ;
Kaplowitz, N. ;
Bjornsson, E. ;
Daly, A. K. .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2011, 89 (06) :806-815
[2]
Drug-induced liver injury:: An analysis of 461 incidences submitted to the Spanish Registry over a 10-year period [J].
Andrade, RJ ;
Lucena, MI ;
Fernández, MC ;
Pelaez, G ;
Pachkoria, K ;
García-Ruiz, E ;
García-Munoz, B ;
González-Grande, R ;
Pizarro, A ;
Durán, JA ;
Jiménez, M ;
Rodrigo, L ;
Romero-Gomez, M ;
Navarro, JM ;
Planas, R ;
Costa, J ;
Borras, A ;
Soler, A ;
Salmerón, J ;
Martin-Vivaldi, R .
GASTROENTEROLOGY, 2005, 129 (02) :512-521
[3]
Acute-on-chronic liver failure in cirrhosis [J].
Arroyo, Vicente ;
Moreau, Richard ;
Kamath, Patrick S. ;
Jalan, Rajiv ;
Gines, Pere ;
Nevens, Frederik ;
Fernandez, Javier ;
To, Uyen ;
Garcia-Tsao, Guadalupe ;
Schnabl, Bernd .
NATURE REVIEWS DISEASE PRIMERS, 2016, 2 :1-18
[4]
Liver Safety Assessment: Required Data Elements and Best Practices for Data Collection and Standardization in Clinical Trials [J].
Avigan, Mark I. ;
Bjornsson, Einar S. ;
Pasanen, Markku ;
Cooper, Charles ;
Andrade, Raul J. ;
Watkins, Paul B. ;
Lewis, James H. ;
Merz, Michael .
DRUG SAFETY, 2014, 37 :S19-S31
[5]
Outcome and prognostic markers in severe drug-induced liver disease [J].
Björnsson, E ;
Olsson, R .
HEPATOLOGY, 2005, 42 (02) :481-489
[6]
Categorization of Drugs Implicated in Causing Liver Injury: Critical Assessment Based on Published Case Reports [J].
Bjornsson, Einar S. ;
Hoofnagle, Jay H. .
HEPATOLOGY, 2016, 63 (02) :590-603
[7]
Patients with elevated liver enzymes are not at higher risk for statin hepatotoxicity [J].
Chalasani, N ;
Aljadhey, H ;
Kesterson, J ;
Murray, MD ;
Hall, SD .
GASTROENTEROLOGY, 2004, 126 (05) :1287-1292
[8]
Features and Outcomes of 899 Patients With Drug-Induced Liver Injury: The DILIN Prospective Study [J].
Chalasani, Naga ;
Bonkovsky, Herbert L. ;
Fontana, Robert ;
Lee, William ;
Stolz, Andrew ;
Talwalkar, Jayant ;
Reddy, K. Rajendar ;
Watkins, Paul B. ;
Navarro, Victor ;
Barnhart, Huiman ;
Gu, Jiezhun .
GASTROENTEROLOGY, 2015, 148 (07) :1340-+
[9]
Risk Factors for Idiosyncratic Drug-Induced Liver Injury [J].
Chalasani, Naga ;
Bjornsson, Einar .
GASTROENTEROLOGY, 2010, 138 (07) :2246-2259
[10]
FDA (Food and Drug Administration Center for Drug Evaluation and Research (CDER)), 2009, GUID IND